ZUCALI, PAOLO ANDREA

ZUCALI, PAOLO ANDREA  

Mostra records
Risultati 1 - 20 di 191 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial 1-gen-2012 Bachner, M; Loriot, Y; Gross-Goupil, M; Zucali, P A; Horwich, A; Germa-Lluch, J-R; Kollmannsberger, C; Stoiber, F; Fléchon, A; Oechsle, K; Gillessen, S; Oldenburg, J; Cohn-Cedermark, G; Daugaard, G; Morelli, F; Sella, A; Harland, S; Kerst, M; Gampe, J; Dittrich, C; Fizazi, K; De Santis, M
721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study 1-gen-2020 Basso, U.; Paolieri, F.; Porta, C. G.; De Giorgi, U.; Bracarda, S.; Antonuzzo, L.; Atzori, F.; Cartenì, G.; Procopio, G.; Fratino, L.; D'Arcangelo, M.; Fornarini, G.; Zucali, P. A.; Cusmai, A.; Santoni, M.; Baldessari, C.; Naglieri, E.; Panni, S.; Zagonel, V.; Tortora, G.
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma 1-gen-2020 Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer 1-gen-2004 Santoro, A.; Cavina, R.; Latteri, F.; Zucali, P. A.; Ginanni, V.; Campagnoli, E.; Ferrari, B.; Morenghi, E.; Pedicini, V.; Roncalli, M.; Alloisio, M.; Ravasi, G.; Soto Parra, H. J.
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 1-gen-2009 Simonelli, M; Banna, G; Navarria, P; Di Ieva, A; Zucali, P; De Vincenzo, F; Gaetani, P; Condorelli, R; Baena, Rry; Scorsetti, M; Santoro, A
Advances in drug treatments for mesothelioma 1-gen-2022 Zucali, Paolo Andrea; De Vincenzo, Fabio; Perrino, Matteo; Digiacomo, Nunzio; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Fazio, Roberta; Pirozzi, Angelo; Santoro, Armando
Advances in the biology of malignant pleural mesothelioma 1-gen-2011 Zucali, Pa; Ceresoli, Gl; De Vincenzo, F; Simonelli, M; Lorenzi, E; Gianoncelli, L; Santoro, A
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer 1-gen-2004 Parra, Hs; Cavina, R; Latteri, F; Zucali, Pa; Campagnoli, E; Morenghi, E; Grimaldi, Gc; Roncalli, M; Santoro, A
Anti-angiogenic therapies for malignant pleural mesothelioma 1-gen-2012 Ceresoli, Giovanni Luca; Zucali, Paolo Andrea
Antiproliferative effects of novel aliphatic acetogenin analogs against aggressive solid tumor cell lines 1-gen-2011 León, Leticia G; Giovannetti, Elisa; Alecci, Claudia; Giancola, Fiorella; Funel, Niccola; Zucali, Paolo; Peters, Godefridus J; Padrón, José M
Assessment of tumor response in malignant pleural mesothelioma 1-gen-2007 Ceresoli, Gl; Chiti, A; Zucali, Pa; Cappuzzo, F; De Vincenzo, F; Cavina, R; Rodari, M; Poretti, D; Lutman, Fr; Santoro, A
Association of Polymorphisms in AKT1 and EGFR with Clinical Outcome and Toxicity in Non-Small Cell Lung Cancer Patients Treated with Gefitinib 1-gen-2010 Giovannetti, E; Zucali, PAOLO ANDREA; Peters, G J; Cortesi, F; D'Incecco, A; Smit, Ef.; Falcone, A; Burgers, J A; Santoro, A; Danesi, R; Giaccone, G; Tibaldi, C; Ri, G E
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors 1-gen-2015 Serpico, D; Trama, A; Haspinger, E R; Agustoni, F; Botta, L; Berardi, R; Palmieri, G; Zucali, P; Gallucci, R; Broggini, M; Gatta, G; Pastorino, U; Pelosi, G; de Braud, F; Garassino, M C
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial 1-gen-2022 Conforti, Fabio; Zucali, Paolo Andrea; Pala, Laura; Catania, Chiara; Bagnardi, Vincenzo; Sala, Isabella; Della Vigna, Paolo; Perrino, Matteo; Zagami, Paola; Corti, Chiara; Stucchi, Sara; Barberis, Massimo; Guerini-Rocco, Elena; Di Venosa, Benedetta; De Vincenzo, Fabio; Cordua, Nadia; Santoro, Armando; Giaccone, Giuseppe; Martino De Pas, Tommaso
Baseline and early change of neutrophil to lymphocyte ratio (bNLR and ΔNLR) as prognostic factors in metastatic renal cell carcinoma (mRCC) treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study 1-gen-2020 Rebuzzi, Sara Elena; Buti, Sebastiano; Maruzzo, Marco; De Giorgi, Ugo; Sbrana, Andrea; Zucali, Paolo Andrea; Fantinel, Emanuela; Procopio, Giuseppe; Merler, Sara; Fratino, Lucia; Baldessari, Cinzia; Ricotta, Riccardo; Massari, Francesco; Banna, Giuseppe Luigi; Soraru', Mariella; Santoni, Matteo; Cortellini, Alessio; Bersanelli, Melissa; Signori, Alessio; Fornarini, Giuseppe
Baseline and early change of systemic inflammation index (bSII and ΔSII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study 1-gen-2020 Rebuzzi, Sara Elena; Atzori, Francesco; Di Napoli, Marilena; Stellato, Marco; Messina, Marco; Chiellino, Silvia; Vignani, Francesca; Cavo, Alessia; Soto Parra, Hector J.; Roviello, Giandomenico; Prati, Veronica; Bimbatti, Davide; De Giorgi, Ugo; Bersanelli, Melissa; Paolieri, Federico; Zucali, Paolo Andrea; Fantinel, Emanuela; Procopio, Giuseppe; Signori, Alessio; Fornarini, Giuseppe
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 1-gen-2021 Di Cosimo, Serena; Tagliaferri, Barbara; Generali, Daniele; Giudici, Fabiola; Agustoni, Francesco; Bernardo, Antonio; Borgonovo, Karen; Farina, Gabriella; Luchena, Giovanna; Luciani, Andrea; Nolè, Franco; Palmeri, Laura; Pietrantonio, Filippo; Poggi, Guido; Zucali, Paolo Andrea; Balletti, Emanuela; Catania, Giovanna; Bernocchi, Ottavia; D'Antonio, Federica; Giordano, Monica; Grossi, Francesco; Lasagna, Angioletta; La Verde, Nicla; Manzoni, Mariangela; Montagna, Benedetta; Olgiati, Angelo; Raimondi, Alessandra; Rampinelli, Irene; Verri, Elena; Zaniboni, Alberto; Di Maio, Massimo; Beretta, Giordano; Danova, Marco
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 1-gen-2019 Ninatti, G; Kirienko, M; Cozzi, L; Voulaz, E; Ricci, F; Carlo-Stella, C; Zucali, P; Chiti, A; Sollini, M
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 1-gen-2018 Imbimbo, M; Ottaviano, M; Vitali, M; Fabbri, A; Leuzzi, G; Fiore, M; Franceschini, D; Pasello, G; Perrino, M; Schiavon, M; Pruneri, G; Tos, Apd; Sangalli, C; Garassino, Mc; Berardi, R; Alessi, A; Calareso, G; Petrini, I; Scorsetti, M; Scotti, V; Rosso, L; Rea, F; Pastorino, U; Casali, Pg; Ramella, S; Ricardi, U; Abate-Daga, L; Torri, V; Trama, A; Palmieri, G; Marino, M; Zucali, Pa
Biology and management of malignant pleural mesothelioma 1-gen-2006 Zucali, Paolo A; Giaccone, Giuseppe